Abstract
BackgroundDisease Modifying Antirheumatic Drugs (DMARDS) are the cornerstone in the pharmacological options for treatment of patients with rheumatoid arthritis. Recent statements from the American College of Rheumatology recommend methotrexate (MTX),...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
